Bank Nifty near key resistance zone; breakout above 54,300 crucial: Ajit Mishra

Indian equity markets are consolidating within a narrow range, with Nifty struggling to break 24,000 and Bank Nifty showing relative strength. Sector rotation is active, offering stock-specific opportunities in pharma, healthcare, energy, auto, and capital market-related stocks. Traders are advised to use range strategies and defined-risk options due to muted overall momentum.

Markets to enter prolonged “drag phase,” not deep correction: Vikas Khemani

Market expert Vikas Khemani anticipates a consolidation phase for Indian equities rather than a sharp breakout, citing persistent global macro uncertainty and sticky energy prices. While corporate earnings have held steady, the full impact of global disruptions is yet to be felt, suggesting a prolonged drag rather than a major fall.

Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap plays

Indian equity markets show a mixed but improving consumption trend, with selective FMCG and premium retail outperforming. Page Industries is highlighted as a strong recovery story, while Nykaa and Honasa are viewed cautiously. The pharma sector continues its outperformance, with Sun Pharma and Aurobindo Pharma looking attractive.

RCF shares jump 7% as Q4 profit soars 158% YoY to Rs 187 crore

Rashtriya Chemicals & Fertilizers shares rose sharply on Friday after the company’s Q4FY26 results showed a 158% YoY surge in net profit to Rs 187 crore and a 49.6% rise in revenue. FY26 profit and revenue also grew strongly, while the company announced a Rs 1.34/share dividend, boosting investor sentiment despite muted long-term stock performance.